X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with JYOTHY LABS - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs JYOTHY LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES JYOTHY LABS AMAR REMEDIES/
JYOTHY LABS
 
P/E (TTM) x -0.5 30.3 - View Chart
P/BV x 0.1 7.5 0.8% View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 AMAR REMEDIES   JYOTHY LABS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
JYOTHY LABS
Mar-16
AMAR REMEDIES/
JYOTHY LABS
5-Yr Chart
Click to enlarge
High Rs164342 48.0%   
Low Rs86237 36.3%   
Sales per share (Unadj.) Rs261.690.9 287.8%  
Earnings per share (Unadj.) Rs17.48.7 199.4%  
Cash flow per share (Unadj.) Rs22.310.5 213.2%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %01.7 0.0%  
Book value per share (Unadj.) Rs100.746.7 215.6%  
Shares outstanding (eoy) m26.16181.12 14.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.53.2 15.0%   
Avg P/E ratio x7.233.2 21.6%  
P/CF ratio (eoy) x5.627.7 20.3%  
Price / Book Value ratio x1.26.2 20.0%  
Dividend payout %057.3 0.0%   
Avg Mkt Cap Rs m3,27052,434 6.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1631,661 9.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,84416,466 41.6%  
Other income Rs m21103 20.5%   
Total revenues Rs m6,86516,568 41.4%   
Gross profit Rs m1,1312,244 50.4%  
Depreciation Rs m128314 40.8%   
Interest Rs m39860 660.0%   
Profit before tax Rs m6261,973 31.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121393 30.8%   
Profit after tax Rs m4551,580 28.8%  
Gross profit margin %16.513.6 121.2%  
Effective tax rate %19.319.9 97.0%   
Net profit margin %6.69.6 69.3%  
BALANCE SHEET DATA
Current assets Rs m4,9044,536 108.1%   
Current liabilities Rs m3,5818,641 41.4%   
Net working cap to sales %19.3-24.9 -77.5%  
Current ratio x1.40.5 260.9%  
Inventory Days Days12440 306.9%  
Debtors Days Days10021 480.1%  
Net fixed assets Rs m1,68910,757 15.7%   
Share capital Rs m262181 144.7%   
"Free" reserves Rs m2,3587,722 30.5%   
Net worth Rs m2,6358,461 31.1%   
Long term debt Rs m50773 697.4%   
Total assets Rs m6,86217,673 38.8%  
Interest coverage x2.633.7 7.6%   
Debt to equity ratio x0.20 2,239.4%  
Sales to assets ratio x1.00.9 107.0%   
Return on assets %12.49.3 134.0%  
Return on equity %17.318.7 92.5%  
Return on capital %31.023.8 130.1%  
Exports to sales %4.00.7 534.4%   
Imports to sales %01.5 0.0%   
Exports (fob) Rs m273123 222.1%   
Imports (cif) Rs mNA242 0.0%   
Fx inflow Rs m273123 222.1%   
Fx outflow Rs m2269 0.7%   
Net fx Rs m271-146 -185.2%   
CASH FLOW
From Operations Rs m-3131,915 -16.3%  
From Investments Rs m-4893 -14,367.6%  
From Financial Activity Rs m769-3,025 -25.4%  
Net Cashflow Rs m-33-1,107 2.9%  

Share Holding

Indian Promoters % 25.5 66.8 38.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 8.4 109.0%  
FIIs % 0.0 14.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 10.3 634.0%  
Shareholders   13,061 84,983 15.4%  
Pledged promoter(s) holding % 99.7 36.7 271.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ CONSUMER  KARUTURI GLOBAL  RELAXO FOOTWEARS  BAJAJ CORP  MARICO LTD  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS